Basso, Manuela
 Distribuzione geografica
Continente #
NA - Nord America 3.266
EU - Europa 449
AS - Asia 163
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 4
OC - Oceania 3
AF - Africa 1
Totale 3.892
Nazione #
US - Stati Uniti d'America 3.262
IT - Italia 176
GB - Regno Unito 72
CN - Cina 66
FI - Finlandia 50
SE - Svezia 49
BG - Bulgaria 42
VN - Vietnam 36
TR - Turchia 28
UA - Ucraina 21
DE - Germania 16
JO - Giordania 16
EU - Europa 6
SG - Singapore 6
NL - Olanda 5
CA - Canada 4
CH - Svizzera 4
IN - India 4
FR - Francia 3
AT - Austria 2
AU - Australia 2
CL - Cile 2
DK - Danimarca 2
JP - Giappone 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BR - Brasile 1
EG - Egitto 1
ES - Italia 1
GR - Grecia 1
ID - Indonesia 1
IE - Irlanda 1
KR - Corea 1
KZ - Kazakistan 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RO - Romania 1
Totale 3.892
Città #
Fairfield 595
Chandler 346
Woodbridge 300
Ashburn 297
Houston 247
Seattle 236
Cambridge 213
Wilmington 209
Ann Arbor 111
Princeton 107
San Mateo 69
Trento 61
Jacksonville 51
New York 48
Dearborn 45
Sofia 42
Como 41
San Diego 36
Helsinki 35
Beijing 29
Dong Ket 28
Izmir 26
London 25
San Paolo di Civitate 15
Norwalk 12
Phoenix 11
Washington 10
Altamura 7
Kilburn 7
Kunming 6
Lawrence 6
Boardman 5
Nanjing 5
Des Moines 4
Hefei 4
Shanghai 4
Toronto 4
Amsterdam 3
Changsha 3
Chicago 3
Lappeenranta 3
Los Angeles 3
Milan 3
Andover 2
Bologna 2
Costa Mesa 2
Dragør 2
Frankfurt am Main 2
Fuzhou 2
Guangzhou 2
Hangzhou 2
Hounslow 2
Islington 2
Lagundo 2
Munich 2
New Bedfont 2
Padova 2
Pune 2
Romainville 2
Rome 2
Schio 2
Shenyang 2
St Louis 2
Tokyo 2
Tolentino 2
Trieste 2
Turin 2
Vienna 2
Wandsworth 2
West Jordan 2
Zurich 2
Almaty 1
Auckland 1
Augusta 1
Bad Bellingen 1
Baku 1
Barsinghausen 1
Bolzano 1
Bonndorf 1
Bremen 1
Brisbane 1
Bupyeong-gu 1
Cairo 1
Chengdu 1
Chiswick 1
Clearwater 1
Dallas 1
Dublin 1
Fremont 1
Genoa 1
Hendon 1
Lavello 1
Leipzig 1
Lima 1
Madrid 1
Miami Beach 1
Naaldwijk 1
New Delhi 1
Nola 1
Palermo 1
Totale 3.400
Nome #
Protein arginine methyltransferase 6 enhances polyglutamine-expanded androgen receptor function and toxicity in spinal and bulbar muscular atrophy. 168
Role of Extracellular Vesicles in Amyotrophic Lateral Sclerosis 140
Antihelminthic benzimidazoles are novel HIF activators that prevent oxidative neuronal death via binding to tubulin. 132
Extracellular Vesicles and a Novel Form of Communication in the Brain 132
Targeting extracellular cyclophilin a reduces neuroinflammation and extends survival in a mouse model of amyotrophic lateral sclerosis 125
Striatal Mutant Huntingtin Protein Levels Decline with Age in Homozygous Huntington's Disease Knock-In Mouse Models 125
Characterization of detergent-insoluble proteins in ALS indicates a causal link between nitrative stress and aggregation in pathogenesis 118
Cu,Zn-superoxide dismutase increases toxicity of mutant and zinc-deficient superoxide dismutase by enhancing protein stability 117
Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration 115
Focus on the heterogeneity of amyotrophic lateral sclerosis 110
Altered ionic currents and amelioration by IGF-1 and PACAP in motoneuron-derived cells modelling SBMA 103
A selective phenelzine analogue inhibitor of histone demethylase LSD1. 95
210th ENMC International Workshop: Research and clinical management of patients with spinal and bulbar muscular atrophy, 27-29 March, 2015, Naarden, The Netherlands 95
Mutations in TGM6 induce the unfolded protein response in SCA35 95
Looking above but not beyond the genome for therapeutics in neurology and psychiatry: epigenetic proteins and RNAs find a new focus. 86
null 86
Rapid Nickel-based Isolation of Extracellular Vesicles from Different Biological Fluids 80
Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: Implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis 77
Transglutaminase is a therapeutic target for oxidative stress, excitotoxicity and stroke: a new epigenetic kid on the CNS block. 76
Hydroxamic acid-based histone deacetylase (HDAC) inhibitors can mediate neuroprotection independent of HDAC inhibition. 76
In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy 72
Hydroxy-substituted trans-cinnamoyl derivatives as multifunctional tools in the context of Alzheimer's disease 72
Histone Deacetylase Inhibitors and Mithramycin A Impact a Similar Neuroprotective Pathway at a Crossroad between Cancer and Neurodegeneration 71
Insoluble mutant SOD1 is partly oligoubiquitinated in amyotrophic lateral sclerosis mice 71
Efficacy of exome-targeted capture sequencing to detect mutations in known cerebellar ataxia genes 71
HIF prolyl hydroxylase inhibitors prevent neuronal death induced by mitochondrial toxins: therapeutic implications for Huntington's disease and Alzheimer's disease 68
Serine phosphorylation and arginine methylation at the crossroads to neurodegeneration 67
Polyglutamine-Expanded Androgen Receptor Alteration of Skeletal Muscle Homeostasis and Myonuclear Aggregation Are Affected by Sex, Age and Muscle Metabolism 66
Utilization of an in vivo reporter for high throughput identification of branched small molecule regulators of hypoxic adaptation 63
null 62
Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by "antioxidant" metal chelators: From ferroptosis to stroke 61
Proteome analysis of human substantia nigra in Parkinson's disease 60
Designing Dual Transglutaminase 2/Histone Deacetylase Inhibitors Effective at Halting Neuronal Death 59
Development of Neh2-luciferase reporter and its application for high throughput screening and real-time monitoring of Nrf2 activators 59
Putting the 'HAT' back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditions 58
Nitroproteomics of peripheral blood mononuclear cells from patients and a rat model of ALS 57
ClC-2-like Chloride Current Alterations in a Cell Model of Spinal and Bulbar Muscular Atrophy, a Polyglutamine Disease 57
Proteomics as a tool to improve investigation of substantial equivalence in genetically modified organisms: the case of a virus-resistant tomato 56
Transglutaminase inhibition protects against oxidative stress-induced neuronal death downstream of pathological ERK activation 53
A case report of late-onset cerebellar ataxia associated with a rare p.R342W TGM6 (SCA35) mutation 52
Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease 50
Transglutaminases, neuronal cell death and neural repair: Implications for traumatic brain injury and therapeutics 50
Proteome analysis of mesencephalic tissues: evidence for Parkinson's disease 48
NurR1 and ERR1 modulate the expression of genes of a DRD2 coexpression network enriched for schizophrenia risk 47
Nitration of Hsp90 induces cell death 45
Protein nitration in a mouse model of familial amyotrophic lateral sclerosis: possible multifunctional role in the pathogenesis 44
Increased transcription of transglutaminase 1 mediates neuronal death in in vitro models of neuronal stress and Aβ1–42-mediated toxicity 42
Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosis 40
Huntingtin-mediated axonal transport requires arginine methylation by PRMT6 37
Clinical, neuropathological, and genetic characterization of STUB1 variants in cerebellar ataxias: a frequent cause of predominant cognitive impairment 33
Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia 32
Neither a novel tau proteinopathy nor an expansion of a phenotype: Reappraising clinicopathology-based nosology 31
Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse 24
Antagonistic effect of cyclin-dependent kinases and a calcium-dependent phosphatase on polyglutamine-expanded androgen receptor toxic gain of function 21
Redox regulation of cyclophilin A by glutathionylation 20
Defective excitation-contraction coupling and mitochondrial respiration precede mitochondrial Ca2+ accumulation in spinobulbar muscular atrophy skeletal muscle 18
LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice 18
In vitro ischemia suppresses hypoxic induction of hypoxia-inducible factor-1α by inhibition of synthesis and not enhanced degradation 18
Motor Neuron Diseases and Neuroprotective Peptides: A Closer Look to Neurons 15
Skeletal Muscle Pathogenesis in Polyglutamine Diseases 10
Spinocerebellar ataxia 38: structure-function analysis shows ELOVL5 G230V is proteotoxic, conformationally altered and a mutational hotspot 9
International Society for Extracellular Vesicles Workshop. QuantitatEVs: multiscale analyses, from bulk to single extracellular vesicle 8
Protein biomarkers for the diagnosis and prognosis of Amyotrophic Lateral Sclerosis 7
Spinal and bulbar muscular atrophy: From molecular pathogenesis to pharmacological intervention targeting skeletal muscle 7
Totale 4.080
Categoria #
all - tutte 21.089
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.089


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019339 0 0 0 0 0 0 0 0 0 0 202 137
2019/2020928 67 37 74 90 90 83 121 96 129 68 43 30
2020/2021918 28 75 85 60 60 107 154 60 44 113 55 77
2021/2022618 39 65 6 15 13 28 14 120 76 75 80 87
2022/2023750 104 107 7 104 53 110 5 75 99 8 42 36
2023/2024275 16 27 33 14 29 81 17 12 29 17 0 0
Totale 4.080